AXON
Price
$513.22
Change
-$28.59 (-5.28%)
Updated
Feb 21 closing price
Capitalization
39.14B
2 days until earnings call
LGVN
Price
$1.56
Change
-$0.08 (-4.88%)
Updated
Feb 21 closing price
Capitalization
23.15M
Ad is loading...

AXON vs LGVN

Header iconAXON vs LGVN Comparison
Open Charts AXON vs LGVNBanner chart's image
Axon Enterprise
Price$513.22
Change-$28.59 (-5.28%)
Volume$1.45M
Capitalization39.14B
Longeveron
Price$1.56
Change-$0.08 (-4.88%)
Volume$102.62K
Capitalization23.15M
AXON vs LGVN Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. LGVN commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Hold and LGVN is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (AXON: $513.22 vs. LGVN: $1.56)
Brand notoriety: AXON and LGVN are both not notable
AXON represents the Aerospace & Defense, while LGVN is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 167% vs. LGVN: 43%
Market capitalization -- AXON: $39.14B vs. LGVN: $23.15M
AXON [@Aerospace & Defense] is valued at $39.14B. LGVN’s [@Biotechnology] market capitalization is $23.15M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $214.48B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $15.48B. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 1 FA rating(s) are green whileLGVN’s FA Score has 1 green FA rating(s).

  • AXON’s FA Score: 1 green, 4 red.
  • LGVN’s FA Score: 1 green, 4 red.
According to our system of comparison, AXON is a better buy in the long-term than LGVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 6 TA indicator(s) are bullish while LGVN’s TA Score has 4 bullish TA indicator(s).

  • AXON’s TA Score: 6 bullish, 4 bearish.
  • LGVN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AXON is a better buy in the short-term than LGVN.

Price Growth

AXON (@Aerospace & Defense) experienced а -24.90% price change this week, while LGVN (@Biotechnology) price change was -6.59% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +0.01%. For the same industry, the average monthly price growth was -3.36%, and the average quarterly price growth was +17.46%.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

AXON is expected to report earnings on May 08, 2025.

LGVN is expected to report earnings on May 10, 2024.

Industries' Descriptions

@Aerospace & Defense (+0.01% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($39.1B) has a higher market cap than LGVN($23.1M). LGVN YTD gains are higher at: -9.827 vs. AXON (-13.646). AXON has higher annual earnings (EBITDA): 408M vs. LGVN (-16.73M). AXON has more cash in the bank: 1.16B vs. LGVN (22.8M). LGVN has less debt than AXON: LGVN (1.6M) vs AXON (721M). AXON has higher revenues than LGVN: AXON (1.94B) vs LGVN (1.89M).
AXONLGVNAXON / LGVN
Capitalization39.1B23.1M169,264%
EBITDA408M-16.73M-2,439%
Gain YTD-13.646-9.827139%
P/E Ratio133.30N/A-
Revenue1.94B1.89M102,483%
Total Cash1.16B22.8M5,079%
Total Debt721M1.6M45,091%
FUNDAMENTALS RATINGS
AXON: Fundamental Ratings
AXON
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
11
SMR RATING
1..100
52
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
56
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXONLGVN
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QCRH76.58-0.09
-0.12%
QCR Holdings
LSTA2.55-0.01
-0.57%
Lisata Therapeutics
STT98.70-0.94
-0.94%
State Street Corp
SSBK31.65-0.95
-2.93%
Southern States Bancshares
MC71.27-2.29
-3.11%
Moelis & Company

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
-5.28%
TECH - AXON
61%
Loosely correlated
-0.87%
VCYT - AXON
58%
Loosely correlated
-4.56%
BEAM - AXON
57%
Loosely correlated
-8.18%
SEER - AXON
56%
Loosely correlated
-1.31%
ADPT - AXON
56%
Loosely correlated
-0.72%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with SRPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-4.88%
SRPT - LGVN
34%
Loosely correlated
-1.96%
ENTA - LGVN
34%
Loosely correlated
-4.18%
FATE - LGVN
33%
Loosely correlated
-8.09%
AXON - LGVN
30%
Poorly correlated
-5.28%
RNA - LGVN
29%
Poorly correlated
-4.33%
More